Halozyme Therapeutics Pre-Tax Income 2010-2024 | HALO

Halozyme Therapeutics pre-tax income for the twelve months ending June 30, 2024 was $0.417B, a 43.75% increase year-over-year.

  • Halozyme Therapeutics annual pre-tax income for 2023 was $0.348B, a 39.94% increase from 2022.
  • Halozyme Therapeutics annual pre-tax income for 2022 was $0.249B, a 0.16% increase from 2021.
  • Halozyme Therapeutics annual pre-tax income for 2021 was $0.249B, a 92.2% increase from 2020.

Halozyme Therapeutics Pre-Tax Income 2010-2024 | HALO

  • Halozyme Therapeutics annual pre-tax income for 2023 was $0.348B, a 39.94% increase from 2022.
  • Halozyme Therapeutics annual pre-tax income for 2022 was $0.249B, a 0.16% increase from 2021.
  • Halozyme Therapeutics annual pre-tax income for 2021 was $0.249B, a 92.2% increase from 2020.